Evidence map›Paper›PMID 36212372›Full record

ArticleFrontiers in plant science2022

Neurofuzzy logic predicts a fine-tuning metabolic reprogramming on elicited

Pascual García-Pérez, Eva Lozano-Milo, Leilei Zhang, Begoña Miras-Moreno, Mariana Landin, Luigi Lucini, Pedro P Gallego

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Impact of Elicitation on Plant Antioxidants Production inAntioxidants (Basel, Switzerland) · 2023
    Article
  4. Bioactive Compounds fromLife (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Pascual García-PérezAgrobiotech for Health, Plant Biology and Soil Science Department, Faculty of Biology, University of Vigo, Vigo, Spain.
Eva Lozano-MiloAgrobiotech for Health, Plant Biology and Soil Science Department, Faculty of Biology, University of Vigo, Vigo, Spain.
Leilei ZhangSustainable Food Process Department, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Begoña Miras-MorenoSustainable Food Process Department, Università Cattolica del Sacro Cuore, Piacenza, Italy.
Mariana LandinPharmacology, Pharmacy, and Pharmaceutical Technology Department, I+D Farma (GI-1645), Faculty of Pharmacy, Instituto de Materiales de la Universidade de Santiago de Compostela (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Luigi LuciniAgrobiotech for Health, Plant Biology and Soil Science Department, Faculty of Biology, University of Vigo, Vigo, Spain.
Pedro P GallegoAgrobiotech for Health, Plant Biology and Soil Science Department, Faculty of Biology, University of Vigo, Vigo, Spain.
Universidade de Vigo · ESUniversità Cattolica del Sacro Cuore · ITUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel approaches to the characterization of medicinal plants as biofactories have lately increased in the field of biotechnology. In this work, a multifaceted approach based on plant tissue culture, metabolomics, and machine learning was applied to decipher and further characterize the biosynthesis of phenolic compounds by eliciting cell suspension cultures from medicinal plants belonging to the

Indexed as

Kalanchoemedicinal plantsmetabolic fingerprintplant biotechnologypolyphenolsUntargeted metabolic profiling

Identifiers

PMID36212372
PMCPMC9541431
OpenAlexW4297065892

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.